Fluoropyrimidine-induced hand-foot syndrome and cardiotoxicity: recommendations for the use of the oral fluoropyrimidine S-1 in metastatic colorectal cancer

BACKGROUND: Fluoropyrimidines (FPs) are an essential part of the majority of systemic regimens in the treatment of metastatic colorectal cancer (CRC). The use of the oral FP S-1 has been approved by the European Medicines Agency as monotherapy or in combination with oxaliplatin or irinotecan, with o...

Descripción completa

Detalles Bibliográficos
Autores principales: Punt, C.J.A., Heinemann, V., Maughan, T., Cremolini, C., Van Cutsem, E., McDermott, R., Bodoky, G., André, T., Osterlund, P., Teske, A.J., Pfeiffer, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163153/
https://www.ncbi.nlm.nih.gov/pubmed/37018874
http://dx.doi.org/10.1016/j.esmoop.2023.101199

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10163153/
https://www.ncbi.nlm.nih.gov/pubmed/37018874
http://dx.doi.org/10.1016/j.esmoop.2023.101199

Ejemplares similares